Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal

NCT05012228 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05012228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05012228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2021
Completion date
December 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal fibrosis, ckd